DNA diagnostic screening likely to become widespread as technology brings down the price
This article was originally published in Clinica
In five years' time, screening a person's DNA to detect cancer and infectious diseases could be commonplace in many hospitals and clinics.
You may also be interested in...
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.